Established in 2018, this manufacturer employs approximately 653 individuals and specializes in offering end-to-end solutions in the pharmaceutical and specialty chemicals industries. As a CTD dossier owner and manufacturer, it holds GMP approvals from multiple international regulatory authorities, including the U.S. FDA, the Therapeutic Goods Administration (TGA) of Australia, and the Malta Medicines Authority (European Union). Additionally, it has received Written Confirmation from the Central Drugs Standard Control Organization (CDSCO) in India, affirming compliance with EU GMP standards for active pharmaceutical ingredients. The manufacturer operates advanced production lines for active pharmaceutical ingredients (APIs) and formulations, adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products and services are utilized across various countries and regions worldwide. With a focus on innovation, efficiency, and agility, the manufacturer is committed to delivering high-standard products that enhance the quality of people's lives.

Established in January 2010, this manufacturer specializes in the contract manufacturing of oral solid dosage forms for both pharmaceuticals and nutraceuticals. As a CTD dossier owner and manufacturer, it holds GMP approvals, ensuring compliance with international quality standards. The manufacturer operates advanced production lines for tablets, capsules, and sachets, adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in various countries worldwide. With a dedicated team experienced in formulation development, the manufacturer is committed to delivering high-quality and regulatory-compliant products